Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alba

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Advances in Therapy|September 17, 2011
Initialization of adjuvant hormonal treatment for breast cancerA Martínez Guisado, A Sánchez Muñoz, M de la Cabeza Lomas Garrido, et al.
British Journal of Cancer|January 25, 2014
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trialE Alba, J Albanell, J de la Haba, et al.
ESMO Open|May 7, 2022
Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancerM Benavides, J Alcaide-Garcia, E Torres, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaJ Aparicio, X García del Muro, P Maroto, et al.
Breast Cancer Research and Treatment|October 12, 2012
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter studyE Alba, J I Chacon, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 studyC Pico, M Martin, C Jara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Advances in Therapy|September 17, 2011
Initialization of adjuvant hormonal treatment for breast cancerA Martínez Guisado, A Sánchez Muñoz, M de la Cabeza Lomas Garrido, et al.
British Journal of Cancer|January 25, 2014
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trialE Alba, J Albanell, J de la Haba, et al.
ESMO Open|May 7, 2022
Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancerM Benavides, J Alcaide-Garcia, E Torres, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaJ Aparicio, X García del Muro, P Maroto, et al.
Breast Cancer Research and Treatment|October 12, 2012
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter studyE Alba, J I Chacon, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 studyC Pico, M Martin, C Jara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Pageof 12